Social conflicts around large carnivores are increasing in Europe, often associated to the species expansion into human-modified and agricultural landscapes. Large carnivores can be seen as an added value by some but as a source of difficulties by others, depending on different values, attitudes, livelihoods, and everyday activities. Therefore, the effective involvement of the different interest groups is important to identify and shape tailored solutions that can potentially be implemented, complementing top-down approaches that might, on their own, result in lack of implementation and buy-in. To improve dialogue in conflictual situations, as part of a European project promoted by the European Parliament, we assessed the practical implementation of participatory processes in three sample areas in Europe where wolves and bears have recently been increasingly impacting human activities. Our results demonstrate that collaboration among different and generally contrasting groups is possible. Even in situations where large-carnivore impacts were seen as unsatisfactorily managed for many years, people were still willing and eager to be involved in alternative discussion processes hoping this would lead to concrete solutions. An important and common highlight among the three study areas was that all the management interventions agreed upon shared the general scope of improving the conditions of the groups most impacted by large carnivores. The process showed the importance of building trust and supporting dialogue for knowledge co-production and mitigation of conflicts between stakeholders and that controversial environmental issues have the potential to trigger a meaningful dialogue about broader societal issues. The direct involvement and support of competent authorities, as well as the upscaling of this process at larger administrative and social scales, remain important challenges.

In normal old (Nold) and Alzheimer’s disease (AD) persons, a high cognitive reserve (CR) makes them more resistant and resilient to brain neuropathology and neurodegeneration. Here, we tested whether these effects may affect neurophysiological oscillatory mechanisms generating dominant resting state electroencephalographic (rsEEG) alpha rhythms in Nold and patients with mild cognitive impairment (MCI) due to AD (ADMCI). Data in 60 Nold and 70 ADMCI participants, stratified in higher (Edu+) and lower (Edu–) educational attainment subgroups, were available in an Italian–Turkish archive. The subgroups were matched for age, gender, and education. RsEEG cortical sources were estimated by eLORETA freeware. As compared to the Nold-Edu– subgroup, the Nold-Edu+ subgroup showed greater alpha source activations topographically widespread. On the contrary, in relation to the ADMCI-Edu– subgroup, the ADMCI-Edu+ subgroup displayed lower alpha source activations topographically widespread. Furthermore, the 2 ADMCI subgroups had matched cerebrospinal AD diagnostic biomarkers, brain gray–white matter measures, and neuropsychological scores. The current findings suggest that a high CR may be related to changes in rsEEG alpha rhythms in Nold and ADMCI persons. These changes may underlie neuroprotective effects in Nold seniors and subtend functional compensatory mechanisms unrelated to brain structure alterations in ADMCI patients.

Growing evidence supports the presence of social cognition deficits and social behavior alterations in major and minor neurocognitive disorders (NCDs). Even though the ability to identify socio-emotional changes has significantly improved in recent years, there is still no specific treatment available. Thus, we explored evidence of drug therapies targeting social cognition alterations in NCDs. Papers were selected according to PRISMA guidelines by searching on the PubMed and Scopus databases. Only papers reporting information on pharmacological interventions for the treatment of social cognition and/or social behavioral changes in major and/or minor NCDs were included. Among the 171 articles entered in the paper selection, only 9 papers were eligible for the scope of the review. Trials testing pharmacological treatments for socio-emotional alterations in NCDs are poor and of low-medium quality. A few attempts with neuroprotective, psychoactive, or immunomodulating drugs have been made. Oxytocin is the only drug specifically targeting the social brain that has been tested with promising results in frontotemporal dementia. Its beneficial effects in long-term use have yet to be evaluated. No recommendation can currently be provided. There is a long way to go to identify and test effective targets to treat social cognition changes in NCDs for the ultimate benefit of patients and caregivers.